Saladax Biomedical, Inc.
- Home
- Companies
- Saladax Biomedical, Inc.
- Products
- MyPaclitaxel - Oncology Therapy
MyPaclitaxel - Oncology Therapy
Neutropenia and neuropathy can be serious side-effects associated with paclitaxel chemotherapy. While hematological toxicities can be addressed, there is no good solution for chemotherapy induced peripheral neuropathy, which is frequent, may be debilitating and can persist or appear after treatment.
Most popular related searches
Recent TDM studies ever demonstrated the potential of paclitaxel dose optimization to:
- Reduce neuropathy
- Reduce neutropenia
- Reduce without impacting survival
